A single-center study to evaluate the efficacy of a fetal urine peptide signature predicting postnatal renal outcome in fetuses with posterior urethral valves

  • Bénédicte Buffin-Meyer
  • Marcin Tkaczyk
  • Małgorzata Stańczyk
  • Benjamin Breuil
  • Justyna Siwy
  • Krzysztof Szaflik
  • Tomasz Talar
  • Justyna Wojtera
  • Waldemar Krzeszowski
  • Stéphane Decramer
  • Julie Klein
  • Joost P. SchanstraEmail author
Original Article



Posterior urethral valves (PUVs) account for 17% of pediatric renal failure. The management of pregnancies involving fetuses with PUV is hampered by the fact that current clinical parameters obtained from fetal ultrasound and/or fetal urine biochemistry are insufficient to predict postnatal renal function. We previously have developed a fetal urine peptide signature (12PUV) that predicted with high precision postnatal renal failure at 2 years of age in fetuses with PUV. Here, we evaluated the accuracy of this signature to predict postnatal renal outcome in fetuses with PUV in an independent single-center study.


Thirty-three women carrying fetuses with suspected PUV were included. Twenty-five fetuses received vesicoamniotic shunts during pregnancy. PUV was confirmed postnatally in 23 patients. Of those 23 fetuses, 2 were lost in follow-up. Four and 3 patients died in the pre- and perinatal periods, respectively. Follow-up renal function at 6 months of age was obtained for the remaining 14 patients. The primary outcome was early renal failure, defined by an eGFR < 60 mL/min/1.73 m2 before 6 months of age or pre- or perinatal death.


The peptide signature predicted postnatal renal outcome in postnatally confirmed PUV fetuses with an AUC of 0.94 (95%CI 0.74–1.0) and an accuracy of 90% (95%CI 78–100). The signature predicted postnatal renal outcome for the suspected PUV cases with an AUC of 0.89 (95%CI 0.72–0.97) and an accuracy of 84% (95%CI 71–97).


This single-center study confirms the predictive power of the previously identified 12PUV fetal urinary peptide signature.


Urinary proteome analysis Prenatal Prediction Outcome Chronic kidney disease Rare disease 



SD and JPS are members of the European Reference Network for Rare Kidney Diseases (ERKNet)– Project ID No 739532.

Funding information

The study was supported by Polish Mothers Memorial Hospital Research Institute (internal grant number 2016/IV/54-GW), by the “Fondation pour la Recherche Médicale” (grant number DEQ20170336759) and by the “Agence de la Biomédecine” (METAPhOR project).

Compliance with ethical standards

Conflict of interest

JS is an employee of Mosaiques diagnostics GmbH (Hannover, Germany) that markets urinary peptide-based diagnostics products.

Supplementary material

467_2019_4390_MOESM1_ESM.xlsx (1.1 mb)
Supplementary Table 1 Normalized abundance of each of the ~5616 fetal urinary peptides in each sample. (XLSX 1115 kb)


  1. 1.
    Agarwal S (1999) Urethral valves. BJU Int 84:570–578CrossRefGoogle Scholar
  2. 2.
    Hodges SJ, Patel B, McLorie G, Atala A (2009) Posterior urethral valves. ScientificWorldJournal 9:1119–1126CrossRefGoogle Scholar
  3. 3.
    Krishnan A, de Souza A, Konijeti R, Baskin LS (2006) The anatomy and embryology of posterior urethral valves. J Urol 175:1214–1220CrossRefGoogle Scholar
  4. 4.
    Morris RK, Quinlan-Jones E, Kilby MD, Khan KS (2007) Systematic review of accuracy of fetal urine analysis to predict poor postnatal renal function in cases of congenital urinary tract obstruction. Prenat Diagn 27:900–911CrossRefGoogle Scholar
  5. 5.
    Morris RK, Malin GL, Khan KS, Kilby MD (2009) Antenatal ultrasound to predict postnatal renal function in congenital lower urinary tract obstruction: systematic review of test accuracy. BJOG 116:1290–1299CrossRefGoogle Scholar
  6. 6.
    Hogan J, Dourthe ME, Blondiaux E, Jouannic JM, Garel C, Ulinski T (2012) Renal outcome in children with antenatal diagnosis of severe CAKUT. Pediatr Nephrol 27:497–502CrossRefGoogle Scholar
  7. 7.
    Stevenson DK, Goldworth A (1998) Ethical dilemmas in the delivery room. Semin Perinatol 22:198–206CrossRefGoogle Scholar
  8. 8.
    Lantos JD, Warady BA (2013) The evolving ethics of infant dialysis. Pediatr Nephrol 28:1943–1947CrossRefGoogle Scholar
  9. 9.
    Klein J, Bascands JL, Mischak H, Schanstra JP (2016) The role of urinary peptidomics in kidney disease research. Kidney Int 89:539–545CrossRefGoogle Scholar
  10. 10.
    Schanstra JP, Zurbig P, Alkhalaf A, Argiles A, Bakker SJ, Beige J, Bilo HJ, Chatzikyrkou C, Dakna M, Dawson J, Delles C, Haller H, Haubitz M, Husi H, Jankowski J, Jerums G, Kleefstra N, Kuznetsova T, Maahs DM, Menne J, Mullen W, Ortiz A, Persson F, Rossing P, Ruggenenti P, Rychlik I, Serra AL, Siwy J, Snell-Bergeon J, Spasovski G, Staessen JA, Vlahou A, Mischak H, Vanholder R (2015) Diagnosis and prediction of CKD progression by assessment of urinary peptides. J Am Soc Nephrol 26:1999–2010CrossRefGoogle Scholar
  11. 11.
    Pontillo C, Jacobs L, Staessen JA, Schanstra JP, Rossing P, Heerspink HJL, Siwy J, Mullen W, Vlahou A, Mischak H, Vanholder R, Zurbig P, Jankowski J (2017) A urinary proteome-based classifier for the early detection of decline in glomerular filtration. Nephrol Dial Transplant 32:1510–1516PubMedGoogle Scholar
  12. 12.
    Decramer S, Wittke S, Mischak H, Zurbig P, Walden M, Bouissou F, Bascands JL, Schanstra JP (2006) Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med 12:398–400CrossRefGoogle Scholar
  13. 13.
    Drube J, Zurbig P, Schiffer E, Lau E, Ure B, Gluer S, Kirschstein M, Pape L, Decramer S, Bascands JL, Schanstra JP, Mischak H, Ehrich JH (2010) Urinary proteome analysis identifies infants but not older children requiring pyeloplasty. Pediatr Nephrol 25:1673–1678CrossRefGoogle Scholar
  14. 14.
    Schanstra JP, Mischak H (2015) Proteomic urinary biomarker approach in renal disease: from discovery to implementation. Pediatr Nephrol 30:713–725CrossRefGoogle Scholar
  15. 15.
    Klein J, Lacroix C, Caubet C, Siwy J, Zuerbig P, Dakna M, Muller F, Breuil B, Stalmach A, Mullen W, Mischak H, Bandin F, Monsarrat B, Bascands J-L, Decramer S, Schanstra JP (2013) Fetal urinary peptides to predict postnatal outcome of renal disease in fetuses with posterior urethral valves (PUV). Sci Transl Med 5:198ra106CrossRefGoogle Scholar
  16. 16.
    Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637CrossRefGoogle Scholar
  17. 17.
    (1997) World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 277:925–926Google Scholar
  18. 18.
    Neuhoff N, Kaiser T, Wittke S, Krebs R, Pitt A, Burchard A, Sundmacher A, Schlegelberger B, Kolch W, Mischak H (2004) Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry. Rapid Commun Mass Spectrom 18:149–156CrossRefGoogle Scholar
  19. 19.
    DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefGoogle Scholar
  20. 20.
    Buffin-Meyer B, Klein J, van der Zanden LFM, Levtchenko E, Moulos P, Lounis N, Conte-Auriol F, Hindryckx A, Wühl E, Persico N, Oepkes O, Schreuder M, Tkaczyk M, Ariceta G, Fossum M, Parvex P, Feitz W, Olsen H, Montini G, Decramer S, Schanstra JP, ANTENATAL Consortium (2019) The ANTENATAL multicenter study to predict postnatal renal outcome in fetuses with posterior urethral valves: objectives and design. Clin Kidney J.
  21. 21.
    Buffin-Meyer B, Klein J, Breuil B, Muller F, Moulos P, Groussolles M, Bouali O, Bascands JL, Decramer S, Schanstra JP (2018) Combination of the fetal urinary metabolome and peptidome for the prediction of postnatal renal outcome in fetuses with PUV. J Proteome 184:1–9CrossRefGoogle Scholar
  22. 22.
    Boizard F, Brunchault V, Moulos P, Breuil B, Klein J, Lounis N, Caubet C, Tellier S, Bascands JL, Decramer S, Schanstra JP, Buffin-Meyer B (2016) A capillary electrophoresis coupled to mass spectrometry pipeline for long term comparable assessment of the urinary metabolome. Sci Rep 6:34453CrossRefGoogle Scholar
  23. 23.
    Nassr AA, Shazly SAM, Abdelmagied AM, Araujo Junior E, Tonni G, Kilby MD, Ruano R (2017) Effectiveness of vesicoamniotic shunt in fetuses with congenital lower urinary tract obstruction: an updated systematic review and meta-analysis. Ultrasound Obstet Gynecol 49:696–703CrossRefGoogle Scholar
  24. 24.
    Dreux S, Rosenblatt J, Moussy-Durandy A, Patin F, Favre R, Lortat-Jacob S, El Ghoneimi A, Oury JF, Deschenes G, Ville Y, Heidet L, Muller F (2018) Urine biochemistry to predict long-term outcomes in fetuses with posterior urethral valves. Prenat Diagn 38:964–970CrossRefGoogle Scholar

Copyright information

© IPNA 2019

Authors and Affiliations

  • Bénédicte Buffin-Meyer
    • 1
    • 2
  • Marcin Tkaczyk
    • 3
  • Małgorzata Stańczyk
    • 3
  • Benjamin Breuil
    • 1
    • 2
  • Justyna Siwy
    • 4
  • Krzysztof Szaflik
    • 5
  • Tomasz Talar
    • 6
  • Justyna Wojtera
    • 5
  • Waldemar Krzeszowski
    • 5
  • Stéphane Decramer
    • 1
    • 2
    • 7
    • 8
  • Julie Klein
    • 1
    • 2
  • Joost P. Schanstra
    • 1
    • 2
    Email author
  1. 1.Institut National de la Santé et de la Recherche Médicale (INSERM), U1048, Institut of Cardiovascular and Metabolic DiseaseToulouseFrance
  2. 2.Université Toulouse III Paul-SabatierToulouseFrance
  3. 3.Department of Pediatrics, Immunology and NephrologyPolish Mother’s Memorial Hospital Research InstituteLodzPoland
  4. 4.Mosaiques diagnostics GmbHHannoverGermany
  5. 5.Department of Genecology, Fertility and Fetal TherapyPolish Mother’s Memorial Hospital - Research InstituteLodzPoland
  6. 6.Department of NeonatologyPolish Mother’s Memorial Hospital - Research InstituteLodzPoland
  7. 7.Service de Néphrologie Pédiatrique, Hôpital des Enfants, CHU ToulouseToulouseFrance
  8. 8.Centre de Référence des Maladies Rénales Rares du Sud-Ouest (SORARE)ToulouseFrance

Personalised recommendations